HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 425 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,950 | +12.3% | 50,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,737 | -6.2% | 50,000 | 0.0% | 0.00% | -20.0% |
| Q1 2023 | $1,851 | -57.6% | 50,000 | -35.0% | 0.01% | -58.3% |
| Q4 2022 | $4,362 | -99.9% | 76,900 | 0.0% | 0.01% | +33.3% |
| Q3 2022 | $3,017,000 | -12.4% | 76,900 | 0.0% | 0.01% | -10.0% |
| Q2 2022 | $3,446,000 | +11.4% | 76,900 | 0.0% | 0.01% | +25.0% |
| Q1 2022 | $3,093,000 | -0.7% | 76,900 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $3,115,000 | +198.9% | 76,900 | +193.5% | 0.01% | +166.7% |
| Q3 2021 | $1,042,000 | -12.4% | 26,200 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,190,000 | +11.0% | 26,200 | 0.0% | 0.00% | -25.0% |
| Q1 2021 | $1,072,000 | -2.7% | 26,200 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,102,000 | +53.1% | 26,200 | -4.7% | 0.00% | +33.3% |
| Q3 2020 | $720,000 | +66.3% | 27,500 | -3.5% | 0.00% | 0.0% |
| Q3 2019 | $433,000 | -42.9% | 28,500 | -36.7% | 0.00% | -25.0% |
| Q2 2019 | $758,000 | +51.0% | 45,000 | +63.6% | 0.00% | +33.3% |
| Q1 2019 | $502,000 | +55.4% | 27,500 | +22.2% | 0.00% | +50.0% |
| Q4 2018 | $323,000 | -35.7% | 22,500 | -18.2% | 0.00% | -33.3% |
| Q3 2018 | $502,000 | +4.6% | 27,500 | -2.5% | 0.00% | 0.0% |
| Q2 2018 | $480,000 | -59.9% | 28,200 | -55.4% | 0.00% | -62.5% |
| Q1 2018 | $1,197,000 | +50.9% | 63,200 | -5.0% | 0.01% | +33.3% |
| Q4 2017 | $793,000 | 0.0% | 66,500 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $793,000 | -8.1% | 66,500 | 0.0% | 0.01% | -14.3% |
| Q2 2017 | $863,000 | -0.3% | 66,500 | 0.0% | 0.01% | -12.5% |
| Q1 2017 | $866,000 | +20.9% | 66,500 | -7.9% | 0.01% | 0.0% |
| Q4 2016 | $716,000 | -9.8% | 72,200 | +8.2% | 0.01% | -11.1% |
| Q3 2016 | $794,000 | +41.3% | 66,700 | 0.0% | 0.01% | +50.0% |
| Q2 2016 | $562,000 | -1.6% | 66,700 | +8.1% | 0.01% | -14.3% |
| Q1 2016 | $571,000 | -49.6% | 61,700 | -5.1% | 0.01% | -46.2% |
| Q4 2015 | $1,132,000 | +31.6% | 65,000 | +1.6% | 0.01% | +30.0% |
| Q3 2015 | $860,000 | -37.5% | 64,000 | +4.9% | 0.01% | -37.5% |
| Q2 2015 | $1,377,000 | +63.9% | 61,000 | +3.7% | 0.02% | +60.0% |
| Q1 2015 | $840,000 | +32.5% | 58,800 | -12.8% | 0.01% | +25.0% |
| Q4 2014 | $634,000 | -5.1% | 67,400 | -8.2% | 0.01% | -11.1% |
| Q3 2014 | $668,000 | -5.2% | 73,400 | +2.8% | 0.01% | -18.2% |
| Q2 2014 | $705,000 | -20.6% | 71,400 | +2.1% | 0.01% | -21.4% |
| Q1 2014 | $888,000 | -9.3% | 69,900 | +8.7% | 0.01% | -12.5% |
| Q4 2013 | $979,000 | +40.1% | 64,300 | +1.6% | 0.02% | +33.3% |
| Q3 2013 | $699,000 | – | 63,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |